Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors

Cell

Volumn 74, Issue 5, 1993, Pages 813-822

  Kemp, Christopher J ^a   Donehower, Lawrence A ^b   Bradley, Allan ^b   Balmain, Allan ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; GENE DOSAGE; GENE INDUCTION; GENE MUTATION; GENE TARGETING; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE RAS; PAPILLOMA; PRIORITY JOURNAL; SKIN TUMOR; TUMOR SUPPRESSOR GENE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMAL; BLOTTING, SOUTHERN; CARCINOMA; DNA; GENES, P53; GENES, RAS; GENOTYPE; HETEROZYGOTE; HUMAN; MALE; MICE; MICE, INBRED STRAINS; PAPILLOMA; SKIN NEOPLASMS; SUPPORT, NON-U.S. GOV'T; TETRADECANOYLPHORBOL ACETATE;

EID: 0027203921     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(93)90461-X     Document Type: Article

References (64)

1. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas
2. Suppression of human colorectal carcinoma cell growth by wild-type p53
3. Oncogene activation in chemical carcinogenesis
4. Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas
5. Functional loss of tumor suppressor genes in multistage chemical carcinogenesis
6. ras genes
7. Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation
8. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis
9. Tumorigenic transformation of spontaneously immortalized fibroblasts from patients with a familial cancer syndrome
10. Mutagenesis of the Ha-ras oncogene in mouse skin tumors induced by polycyclic aromatic hydrocarbons
11. Genetic changes in skin tumor progression: correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7
12. Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression
13. Loss of heterozygosity and mutational alterations of the p53 gene in skin tumors of interspecific hybrid mice
14. p53 functions as a cell cycle control protein in osteosarcomas
15. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
16. Wild-type p53 can inhibit oncogene-mediated focus formation
17. Dual evolutionary origin for the rat genetic sequences of Harvey murine sarcoma virus
18. A genetic model for colorectal tumorigenesis
19. Expression of the normal p53 gene induces differentiation of K562 cells
20. The p53 proto-oncogene can act as a suppressor of transformation
21. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression
22. Tumor induction in initiated mouse skin by phorbol esters and methyl methanesulfonate: correlation between chromosomal damage and conversion (“stage I of tumor promotion”) in vivo
23. Identification and characterization of the familial adenomatous polyposis coli gene
24. Mutational activation of oncogenes in animal model systems of carcinogenesis
25. Expression of p53 in premalignant and malignant squamous epithelium
26. In vitro groth characteristics of embryo fibroblasts isolated from p53-deficient mice
27. Induction of papillomas with a high probability of conversion to malignancy
28. Organization, distribution and stability of endogenous ecotropic murine leukemia virus DNA sequences in chromosomes of Mus musculus
29. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in Ataxia-Telangiectasia
30. Identification of FAP locus genes from chromosome 5q21
31. Pathology of human and experimental skin tumors
32. Reduction to homozygosity is the predominant spontaneous mutational event in cultured human lymphoblastoid cells
33. Simplified mammalian DNA isolation procedure
34. p53, guardian of the genome
35. p53: oncogene or anti-oncogene
36. Loss of constitutional heterozygosity in human cancer
37. A cancer family syndrome in twenty-four kindreds
38. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
39. Mutator phenotype may be required for multistage carcinogenesis
40. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms
41. Tumor suppressor genes
42. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53
43. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53
44. The clonal nature of neoplasia
45. Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation
46. APC mutations occur early during colorectal tumorigenesis
47. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis
48. Alterations of the p53 tumor suppressor gene during mouse skin tumor progression
49. Involvement of wild-type p53 in pre-B-cell differentiation in vitro
50. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line
51. Clonal expansion of p53 mutant cells is associated with brain tumour progression
52. Germ line transmission of a mutated p53 gene in a family with Li-Fraumeni syndrome
53. Transfection with plasmid pSV2ptEJ induces chromosome rearrangements in CHEF cells
54. An experimental approach to cancer
55. Evolution of cancer genes as a mutation-driven process
56. Cancer: a deadly inheritance
57. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma
58. Oncogenes, antioncogenes, and the molecular basis of multistep carcinogenesis
59. Somatic mutations at a heterozygous autosomal locus in human cells occur more frequently by allele-loss than by intragenic structural alterations
60. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles
61. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
62. p53-mediated cell death: relationship to cell cycle control
63. Altered growth and differentiation of cultured mouse epidermal cells infected with oncogenic retrovirus: contrasting effects of viruses and chemicals